Literature DB >> 187156

Mucolipidosis IV. Clinical, ultrastructural, histochemical, and chemical studies of a case, including a brain biopsy.

I Tellez-Nagel, I Rapin, T Iwamoto, A B Johnson, W T Norton, H Nitowsky.   

Abstract

A 7-year-old Ashkenazi Jewish boy with normal early development started to regress at 8 months of age and made no further developmental progress. Corneal clouding was noted at age 10 months. Corneal and conjunctival biopsy at 14 months, cerebral biopsy at 24 months, and fibroblast cultures at 32 months showed lysosomal inclusions, suggesting the storage of lipid-like and mucopolysaccharide-like material. In the brain, dense fluorescent inclusions resembled those in ceroid-lipofuscinosis. Total ganglioside content of white matter was raised, but the pattern was normal. The level of nonlipid hexosamine in the brain was normal. The cornea and conjunctiva contained electronlucent vacuoles resembling those in the mucopolysaccharidoses. Cornea, brain, and lymphocytes contained concentric membranous lamellar structures reminiscent of those in the gangliosidoses. The clinical picture and ultrastructural findings support the impression that this case belongs to a new variant of the mucolipidoses, mucolipidosis IV.

Entities:  

Mesh:

Year:  1976        PMID: 187156     DOI: 10.1001/archneur.1976.00500120032005

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  36 in total

1.  G(M2)-ganglioside metabolism in situ in mucolipidosis IV fibroblasts.

Authors:  S Raghavan; E Leshinsky; E H Kolodny
Journal:  Neurochem Res       Date:  1999-04       Impact factor: 3.996

2.  Mucolipidosis type IV: abnormal transport of lipids to lysosomes.

Authors:  R Bargal; G Bach
Journal:  J Inherit Metab Dis       Date:  1997-09       Impact factor: 4.982

3.  N-butyldeoxynojirimycin delays motor deficits, cerebellar microgliosis, and Purkinje cell loss in a mouse model of mucolipidosis type IV.

Authors:  Lauren C Boudewyn; Jakub Sikora; Ladislav Kuchar; Jana Ledvinova; Yulia Grishchuk; Shirley L Wang; Kostantin Dobrenis; Steven U Walkley
Journal:  Neurobiol Dis       Date:  2017-06-10       Impact factor: 5.996

4.  Morphological changes in CNS of rats treated with perhexiline maleate (pexid).

Authors:  H J Jung; K Suzuki
Journal:  Acta Neuropathol       Date:  1978-06-30       Impact factor: 17.088

5.  Novel degenerative and developmental defects in a zebrafish model of mucolipidosis type IV.

Authors:  Huiqing Li; Wuhong Pei; Sivia Vergarajauregui; Patricia M Zerfas; Nina Raben; Shawn M Burgess; Rosa Puertollano
Journal:  Hum Mol Genet       Date:  2017-07-15       Impact factor: 6.150

6.  Novel Role of TRPML2 in the Regulation of the Innate Immune Response.

Authors:  Lu Sun; Yinan Hua; Silvia Vergarajauregui; Heba I Diab; Rosa Puertollano
Journal:  J Immunol       Date:  2015-10-02       Impact factor: 5.422

Review 7.  Mucolipin 1: endocytosis and cation channel--a review.

Authors:  Gideon Bach
Journal:  Pflugers Arch       Date:  2004-11-27       Impact factor: 3.657

8.  Mucolipidosis IV, a sialolipidosis due to ganglioside sialidase deficiency.

Authors:  L Caimi; G Tettamanti; B Berra; F Omodeo Sale; C Borrone; R Gatti; P Durand; J J Martin
Journal:  J Inherit Metab Dis       Date:  1982       Impact factor: 4.982

9.  The tissue-specific expression of TRPML2 (MCOLN-2) gene is influenced by the presence of TRPML1.

Authors:  Mohammad A Samie; Christian Grimm; Jeffrey A Evans; Cyntia Curcio-Morelli; Stefan Heller; Susan A Slaugenhaupt; Math P Cuajungco
Journal:  Pflugers Arch       Date:  2009-11       Impact factor: 3.657

10.  Neurologic, gastric, and opthalmologic pathologies in a murine model of mucolipidosis type IV.

Authors:  Bhuvarahamurthy Venugopal; Marsha F Browning; Cyntia Curcio-Morelli; Andrea Varro; Norman Michaud; Nanda Nanthakumar; Steven U Walkley; James Pickel; Susan A Slaugenhaupt
Journal:  Am J Hum Genet       Date:  2007-10-02       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.